Beckman Coulter to Distribute IntelliCyt's HyperCyt System | GenomeWeb

NEW YORK (GenomeWeb News) – Beckman Coulter has inked a deal to be exclusive distributor outside of North America for IntelliCyt's HyperCyt system, an automated platform for multiplex cell- and bead-based screening.

Beckman also will hold co-exclusive distribution rights to the system in North America for use on its own CyAn flow cytometer. Beckman said that the combination will "create the fastest available flow cytometric cell analysis system."

Albuquerque, NM-based IntelliCyt will continue to provide direct sales and support of its HyperCyt system in North America.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.